Market Place
Filter By Unselect All
Sub Category Unselect See All
Country Unselect See All
Companies Unselect See All
Selected Filter(s): Reset All
- Category Reset
- Sub Category Reset
- Country Reset
Phase 1 Clinical Pharmacology Study 
Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa
Quotient has the experience and expertise to deliver studies with the highest quality service and speed to clinical data. If you need a complete service including data management, data analysis, statistics and medical writing, Quotient is your answer.
Website
Radiolabeled ADME Studies
Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics
In response to a growing interest in conducting human 14C-radiolabeled ADME studies earlier in drug development, Celerion has expanded its ADME suite in Lincoln, Nebraska.
14C ADME / Mass Balance
Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics
Whatever Phase 1 clinical pharmacology study you require, at Quotient Sciences you can expect rapid study startup and rapid recruitment through our locations in Jacksonville, Miami and Nottingham.
Clinical Development Services & Solutions
Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa
Chiltern provides the following services for Phase llb - III Late-stage programs: Protocol feasibility and design, CRF development, Recruitment, Data management, Medical writing, Biostatistics, Drug safety monitoring committees
Early Development Clinical Research Services
Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa
Program services offered by both clinics range from medical writing, clinical conduct and data management to monitoring, biostatistics and clinical pharmacology.
Supporting Drug Development at Phase III
Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa
MPI Research is a full early-stage drug development CRO that partners with biopharmaceutical, biotechnology, medical device, animal health, and chemical industries to advance global healthcare. MPI Research supports all phases of the drug development pathway, ranging from target identification
Supporting Drug Development at Phase I & II
Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa
MPI Research is a full early-stage drug development CRO that partners with biopharmaceutical, biotechnology, medical device, animal health, and chemical industries to advance global healthcare. MPI Research supports all phases of the drug development pathway, ranging from target identification
14C-Radiolabeled Microtracer Studies
Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics
Celerion’s clinic in Lincoln, Nebraska, is the only Phase I facility in North America with proven experience to release radiolabeled drug to regulatory standards that has been formulated on site for intravenous use in humans. This is required to perform assessments of absolute bioavailability
Global CRO- Phase I & ll Studies
Clinical Trials >> Early Clinical / Phase I-IIa >> Phase I / IIa
With over 40 years of experience, more than 600 beds in North America and Europe, Celerion offers the largest global Phase I and II clinical operations networks in the industry.
Clinical PK/PD and Pharmacometrics Services
Clinical Trials >> Early Clinical / Phase I-IIa >> Pharmacokinetics / Pharmacodynamics / Pharmacometrics
PAREXEL’s global team of experienced clinical pharmacokineticists and pharmacometricians offer unsurpassed expertise in Clinical PK/PD and Pharmacometrics, from pre-clinical to Phase III studies.